Newsroom
News and Announcements - All
- PCORnet® Resources to Power Study Exploring the Relationship Between COVID-19 and Diabetes August 3, 2023
A large new study will use PCORnet® to explore the relationship between COVID-19 and diabetes with the goal of guiding future treatment interventions and public health approaches. Vanderbilt University Medical Center (VUMC) received a four-year, $28 million grant from the ...
- Smoother Processes, Better Data Curation: A Longtime Network User Speaks to the Evolution of PCORnet® July 27, 2023Flash back to 2016, when Hamilton had just premiered on Broadway, the Rio Olympics were in full swing, and Duke University cardiologist Neha Pagidipati first heard about a relatively new network of clinical research networks capable of producing granular insights ...
- We’ve Come a Long Way: Celebrating Research Progress on International Clinical Trials Day May 19, 2023Every year on May 20, the date of the first-ever clinical trial conducted by James Lind in 1747, the world marks International Clinical Trials Day. It’s a time to celebrate all that has been accomplished by the clinical research community—clinicians, ...
- (Almost) 10 Years of PCORnet®: Reflecting on the Network’s Growth and Looking Ahead May 12, 2023PCORnet® stakeholders and leadership team members recently gave a National Institutes of Health (NIH) Collaboratory Grand Rounds webinar presentation on the near decade of research powered by PCORnet, including key accomplishments and the evolution of the Network. The presentation featured ...
- Five ways patients win with PPRL in PCORnet® March 21, 2023Electronic health records (EHRs), administrative claims databases, and other patient data are important sources of healthcare information that can be used for research. However, they live in separate systems, which means researchers typically can’t easily combine insights to understand a ...
- Rigorous patient privacy + connected insights: With PPRL, PCORnet® researchers can have the best of both February 20, 2023Two recent manuscripts published in the journal BMC Research Notes and JAMIA describe the framework and implementation of a new method of connecting patient data across disparate healthcare ecosystems in PCORnet while maintaining the highest levels of privacy and security. ...
- Two RECOVER Studies Leverage PCORnet® for New Insights on ‘Long COVID’ December 19, 2022
As COVID-19 viral variants continue to spread, so too grows the population of those who experience COVID-19’s effects months after the acute illness has passed. Now two new manuscripts in Nature Medicine and JAMA Pediatrics show how the RECOVER initiative ...
- Use of Smartphone Technology Won’t Yield Lower Blood Pressure Readings, Says New PCORnet® Research October 25, 2022Mobile technology is fueling new frontiers in healthcare, promising easier management of chronic conditions through applications that send reminders, record readings, track trend lines, and allow users to share results with their clinician at the push of a button. In ...
- Which of the Two Newer Classes of Diabetes Drugs is Better? Patients and PCORnet® Will Guide Answers August 29, 2022Two newer classes of type 2 diabetes medications have the potential to transform the way people manage the condition that currently impacts more than 32 million Americans. Recent studies have shown that sodium-glucose cotransporter-2 inhibitors (SGLT2i) and glucagon-like peptide-1 receptor ...
- PCORnet® Is Helping Researchers Unravel the Mystery of Long-Haul COVID August 22, 2022Today, almost 60 percent of the U.S. has been infected with COVID-19, a figure the CDC says is likely a conservative estimate. While most people infected recover fully in a matter of weeks, millions of people continue to suffer the ...
A large new study will use PCORnet® to explore the relationship between COVID-19 and diabetes with the goal of guiding future treatment interventions and public health approaches. Vanderbilt University Medical Center (VUMC) received a four-year, $28 million grant from the ...
Flash back to 2016, when Hamilton had just premiered on Broadway, the Rio Olympics were in full swing, and Duke University cardiologist Neha Pagidipati first heard about a relatively new network of clinical research networks capable of producing granular insights ...
Every year on May 20, the date of the first-ever clinical trial conducted by James Lind in 1747, the world marks International Clinical Trials Day. It’s a time to celebrate all that has been accomplished by the clinical research community—clinicians, ...
PCORnet® stakeholders and leadership team members recently gave a National Institutes of Health (NIH) Collaboratory Grand Rounds webinar presentation on the near decade of research powered by PCORnet, including key accomplishments and the evolution of the Network. The presentation featured ...
Electronic health records (EHRs), administrative claims databases, and other patient data are important sources of healthcare information that can be used for research. However, they live in separate systems, which means researchers typically can’t easily combine insights to understand a ...
Two recent manuscripts published in the journal BMC Research Notes and JAMIA describe the framework and implementation of a new method of connecting patient data across disparate healthcare ecosystems in PCORnet while maintaining the highest levels of privacy and security. ...
As COVID-19 viral variants continue to spread, so too grows the population of those who experience COVID-19’s effects months after the acute illness has passed. Now two new manuscripts in Nature Medicine and JAMA Pediatrics show how the RECOVER initiative ...
Mobile technology is fueling new frontiers in healthcare, promising easier management of chronic conditions through applications that send reminders, record readings, track trend lines, and allow users to share results with their clinician at the push of a button. In ...
Two newer classes of type 2 diabetes medications have the potential to transform the way people manage the condition that currently impacts more than 32 million Americans. Recent studies have shown that sodium-glucose cotransporter-2 inhibitors (SGLT2i) and glucagon-like peptide-1 receptor ...
Today, almost 60 percent of the U.S. has been infected with COVID-19, a figure the CDC says is likely a conservative estimate. While most people infected recover fully in a matter of weeks, millions of people continue to suffer the ...
